본문 바로가기
KERD
논문KCI 등재

Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Patients with severe coronavirus disease 2019 (COVID-19) demonstrate dysregulated immune responses including exacerbated neutrophil functions. Massive neutrophil infiltrations accompanying neutrophil extracellular trap (NET) formations are also observed in patients with severe COVID-19. However, the mechanism underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced NET formation has not yet been elucidated. Here we show that 2 viral proteins encoded by SARS-CoV-2, the nucleocapsid protein and the whole spike protein, induce NET formation from neutrophils. NET formation was ROS-independent and was completely inhibited by the spleen tyrosine kinase inhibition. The inhibition of p38 MAPK, protein kinase C, and JNK signaling pathways also inhibited viral protein-induced NET formation. Our findings demonstrate one method by which SARS-CoV-2 evades innate immunity and provide a potential target for therapeutics to treat patients with severe COVID-19.

Abstract

Patients with severe coronavirus disease 2019 (COVID-19) demonstrate dysregulated immune responses including exacerbated neutrophil functions. Massive neutrophil infiltrations accompanying neutrophil extracellular trap (NET) formations are also observed in patients with severe COVID-19. However, the mechanism underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced NET formation has not yet been elucidated. Here we show that 2 viral proteins encoded by SARS-CoV-2, the nucleocapsid protein and the whole spike protein, induce NET formation from neutrophils. NET formation was ROS-independent and was completely inhibited by the spleen tyrosine kinase inhibition. The inhibition of p38 MAPK, protein kinase C, and JNK signaling pathways also inhibited viral protein-induced NET formation. Our findings demonstrate one method by which SARS-CoV-2 evades innate immunity and provide a potential target for therapeutics to treat patients with severe COVID-19.

참고문헌 (32)

  1. Mehta P, "Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression", Lancet, 395, pp.1033~1034 (2020)
  2. Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention", Nat Rev Immunol, 20, pp.363~374 (2020)
  3. Vabret N, "Immunology of COVID-19 : current state of the science", Immunity, 52, pp.910~941 (2020)
  4. Barnes BJ, "Targeting potential drivers of COVID-19 : neutrophil extracellular traps", J Exp Med, 217, pp.e20200652~ (2020)
  5. Fox SE, "Pulmonary and cardiac pathology in African American patients with COVID-19 : an autopsy series from New Orleans", Lancet Respir Med, 8, pp.681~686 (2020)
  6. Zuo Y, "Neutrophil extracellular traps in COVID-19", JCI Insight, 5, pp.e138999~ (2020)
  7. Schulte-Schrepping J, "Severe COVID-19 is marked by a dysregulated myeloid cell compartment", Cell, 182, pp.1419.e23~1440.e23 (2020)
  8. Németh T, "Neutrophils as emerging therapeutic targets", Nat Rev Drug Discov, 19, pp.253~275 (2020)
  9. Fuchs TA, "Extracellular DNA traps promote thrombosis", Proc Natl Acad Sci U S A, 107, pp.15880~15885 (2010)
  10. Skendros P, "Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis", J Clin Invest, 130, pp.6151~6157 (2020)
  11. Park SY, "Autophagy primes neutrophils for neutrophil extracellular trap formation during sepsis", Am J Respir Crit Care Med, 196, pp.577~589 (2017)
  12. Shrestha S, "Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype", OncoImmunology, 5, pp.e1067744~ (2015)
  13. Dosch SF, "SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro", Virus Res, 142, pp.19~27 (2009)
  14. Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271.e8~280.e8 (2020)
  15. Narasaraju T, "Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis", Am J Pathol, 179, pp.199~210 (2011)
  16. Douda DN, "Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping", J Immunol, 187, pp.1856~1865 (2011)
  17. Liu J, "Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage", J Transl Med, 18, pp.206~ (2020)
  18. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
  19. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
  20. Feng Z, "The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)directly decimates human spleens and lymph nodes", medRxiv. doi: 10.1101, 2020 (2020)
  21. Okba NMA, "Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients", Emerg Infect Dis, 26, pp.1478~1488 (2020)
  22. Hoving JC, "Signalling C-type lectin receptors, microbial recognition and immunity", Cell Microbiol, 16, pp.185~194 (2014)
  23. Mócsai A, "The syk tyrosine kinase : a crucial player in diverse biological functions", Nat Rev Immunol, 10, pp.387~402 (2010)
  24. Gramberg T, "LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus", Virology, 340, pp.224~236 (2005)
  25. Jeffers SA, "CD209L(L-SIGN)is a receptor for severe acute respiratory syndrome coronavirus", Proc Natl Acad Sci U S A, 101, pp.15748~15753 (2004)
  26. Thomas CJ, "Pattern recognition receptor function in neutrophils", Trends Immunol, 34, pp.317~328 (2013)
  27. Pavan Gollapalli, "Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain–human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2", Journal of Biomolecular Structure and Dynamics, pp.1~14 (2020), Informa UK Limited[DOI]
  28. Watanabe Y, "Site-specific glycan analysis of the SARS-CoV-2spike", Science, 369, pp.330~333 (2020)
  29. Grant OC, "Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition", Sci Rep, 10, pp.14991~ (2020)
  30. Li X, "The β-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance", Cell Host Microbe, 10, pp.603~615 (2011)
  31. Strasser D, "Syk kinase-coupled C-type lectin receptors engage protein kinase C-δ to elicit Card9 adaptor-mediated innate immunity", Immunity, 36, pp.32~42 (2012)
  32. Jacinto E, "Cooperation between syk and Rac1 leads to synergistic JNK activation in T lymphocytes", Immunity, 8, pp.31~41 (1998)

관련 논문AI추천

이 간행물의 다른 논문 (5건)